Primary Central Nervous System Lymphoma in the Elderly

Publisher： Karger

E-ISSN： 2296-5262|37|7-8|376-377

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.7-8, 2014-07, pp. : 376-377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prognosis Factors in Japanese Elderly Patients with Primary Central Nervous System Lymphoma Treated with a Nonradiation, Intermediate-Dose Methotrexate-Containing Regimen

By  

Oncology Research and Treatment, Vol. 37, Iss. 7-8, 2014-05 ,pp. : 378-383

Karger

Access to resources Recommend Favorite

Primary Central Nervous System Lymphoma in an Asian Population: A 15-Year Experience

By  

Oncology Research and Treatment, Vol. 29, Iss. 10, 2006-09 ,pp. : 455-459

Karger

Access to resources Recommend Favorite

Rituximab with high‐dose methotrexate in primary central nervous system lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : 1149-1154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary Sarcomas of the Central Nervous System

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 210-214

Karger

Access to resources Recommend Favorite

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000‐2013

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 61-68

John Wiley & Sons Inc

Access to resources Recommend Favorite